Advertisement
Research Article| Volume 7, ISSUE 3, P513-529, September 1987

Download started.

Ok

Monitoring Aminoglycoside Therapy

  • Richard E. Mullins
    Correspondence
    Corresponding author: Emory University Hospital, Clinical Chemistry Laboratory, Atlanta, Georgia 30322
    Affiliations
    Assistant Professor, Department of Pathology and Laboratory Medicine, Emory University School of Medicine; Co-Director, Division of Clinical Chemistry, and Technical Director, Therapeutic Drug Monitoring Team, Emory University Hospital, Atlanta, Georgia
    Search for articles by this author
  • Victor Lampasona
    Affiliations
    Adjunct Associate Director, Mercer University Southern School of Pharmacy; Therapeutic Drug Monitoring Team Leader, and Director for Clinical and Educational Programs, Department of Pharmaceutical Services, Emory University Hospital, Atlanta, Georgia
    Search for articles by this author
  • Rex B. Conn
    Affiliations
    Professor and Vice Chairman, Department of Pathology and Cell Biology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30727-3
Monitoring Aminoglycoside Therapy
Previous ArticleAntimicrobial Susceptibility Tests and Their Role in Therapeutic Drug Monitoring
Next ArticleChloramphenicol and Vancomycin
      This paper is only available as a PDF. To read, Please Download here.
      The aminoglycoside antibiotics are indispensible therapeutic agents; however, a high incidence of toxic effects mandates that they be used with caution. Monitoring of serum aminoglycoside concentrations is essential in many types of patients, such as those having compromised renal function, those receiving a maximum dose of the drug, the obese, the elderly, and patients with cystic fibrosis.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Anhalt J.P.
        • Brown S.D.
        High-performance liquid chromatographic assay of aminoglycoside antibiotics in serum.
        Clin Chem. 1978; 24: 1940-1947
        • Ashby C.D.
        • Lewis J.E.
        • Nelson J.C.
        Measurement of three aminoglycoside antibiotics with a single radioimmunoassay system.
        Clin Chem. 1978; 24: 1734-1737
      3. Barnes W.G. Hodges G.R. The Aminoglycoside Antibiotics: A Guide to Therapy. CRC Press, Boca Raton, Florida1984
        • Barza M.
        • Lauermann M.
        Why monitor serum levels of gentamicin?.
        Clin Pharmacokinet. 1978; 3: 202-215
        • Bauer L.A.
        Rebound gentamicin levels after hemodialysis.
        Ther Drug Monit. 1982; 4: 99-101
        • Bergan T.
        • Brodwall E.K.
        • Westlie L.
        • et al.
        Renal excretion of gentamicin and effect of probenicid.
        Acta Pathol Microbiol Scand. 1973; 241: 95-98
        • Bryan L.E.
        • Van Den Elzen H.M.
        Effect of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: A model for entry of streptomycin and gentamicin in susceptible and resistant bacteria.
        Antimicrob Agents Chemother. 1977; 12: 163-177
        • Bryan L.E.
        • Nicas T.
        • Holloway B.W.
        • et al.
        Aminoglycoside-resistant mutation of Pseudomonas aeruginosa defective in cytochrome C552 and nitrate reductase.
        Antimicrob Agents Chemother. 1980; 17: 71-79
        • Burd J.F.
        • Wong R.C.
        • Feeney J.E.
        • et al.
        Homogenous reactant-labeled fluorescent immunoassay for therapeutic drugs exemplified by gentamicin determination in human serum.
        Clin Chem. 1977; 23: 1402-1408
        • Burkle W.S.
        Comparative evaluation of the aminoglycoside antibiotics for systemic use.
        Drug Inteil Clin Pharm. 1981; 15: 847-862
        • Chan R.A.
        • Benner E.J.
        • Hoeprich P.D.
        Gentamicin therapy in renal failure: A nomogram for dosage.
        Ann Intern Med. 1972; 76: 773-778
        • Chow M.
        • Deglin J.
        • Harralson A.
        • et al.
        Prediction of gentamicin serum levels using a one-compartment open linear pharmacokinetic model.
        Am J Hosp Pharm. 1978; 35: 1078-1081
        • Cipolle R.J.
        • Zaske D.E.
        • Crossley K.
        Gentamicin/tobramycin: Therapeutic use and serum concentration monitoring.
        in: Taylor W.J. Finn A.L. Individualizing Drug Therapy: Practical Applications of Drug Monitoring. Volume 1. Gross, Townsend, Frank, New York1981
        • Clarke J.S.
        • Condon R.E.
        • Bartlet J.G.
        • et al.
        Preoperative oral antibiotics reduce septic complications of colon operations.
        Ann Surg. 1977; 186: 251-259
        • Craig W.A.
        • Suh B.
        Protein binding and the antimicrobial effects. Methods for the determination of protein binding.
        in: Lorian V. Antibiotics in Laboratory Medicine. Edition 2. Williams & Wilkins, Baltimore1986: 477-514
        • Crass R.E.
        • Lampasona V.
        Aminoglycosides.
        in: Gambino R. Clinical Pharmacology. American Society of Clinical Pathologists, Chicago1985 (ASCP Check Sample, No. CP 85-3.)
        • Creatsas G.
        • Lolis D.
        • Pavlatos M.
        • et al.
        Gentamicin in the treatment of lower genital tract infections: Level of the drug in menses, cervical mucus and vaginal fluid.
        Int J Clin Pharmacol Biopharm. 1979; 17: 225-227
        • Dworzack D.L.
        Aminoglycosides: Mechanisms of action and resistance.
        in: Barnes W.G. Hodges G.R. The Aminoglycoside Antibiotics: A Guide to Therapy. CRC Press, Boca Raton, Florida1984: 24-44
        • Edwards C.Q.
        • Smith C.R.
        • Baughman K.L.
        • et al.
        Concentrations of gentamicin and amikacin in human kidneys.
        Antimicrob Agents Chemother. 1976; 9: 925-927
        • Ericsson C.D.
        • Duke Jr, J.H.
        • Pickering L.K.
        Clinical pharmacology of intravenous and intraperitoneal aminoglycoside antibiotics in the prevention of wound infection.
        Ann Surg. 1978; 188: 66-70
        • Evans S.
        • Leung K.
        • Tokarski R.
        • et al.
        Radial partition immunoassay: Monitoring gentamicin levels in serum and plasma (abstract).
        Clin Chem. 1984; 30: 1025
        • Evans W.E.
        • Feldman S.
        • Barker L.F.
        • et al.
        Use of gentamicin serum levels to individualize therapy in children.
        J Pediatr. 1978; 93: 133-137
        • Fevery J.
        Concentrations of gentamicin in ascitic fluid after IV infusion.
        Neth J Med. 1983; 26: 191-192
        • Gill M.A.
        • Cohen J.L.
        • Chenella F.C.
        • et al.
        Gentamicin penetration into diseased appendix tissue.
        Ther Drug Monit. 1984; 6: 298-301
        • Goetz D.R.
        • Pancorbo S.
        • Hoag S.
        • et al.
        Prediction of serum gentamicin concentrations in patients undergoing hemodialysis.
        Am J Hosp Pharm. 1980; 37: 1077-1083
        • Haas M.J.
        • Davies J.
        Enzymatic acetylation as a means of determining serum aminoglycoside concentrations.
        Antimicrob Agents Chemother. 1973; 4: 497-499
        • Hamilton R.A.
        • Chow M.S.
        Two-point method for determination of aminoglycoside pharmacokinetics: Theoretical and practical considerations.
        Ther Drug Monit. 1986; 8: 274-278
        • Hodges G.R.
        Aminoglycoside toxicity.
        in: Barnes W.G. Hodges G.R. The Aminoglycoside Antibiotics: A Guide to Therapy. CRC Press, Boca Raton, Florida1984: 153-179
        • Holmes R.K.
        • Sanford J.P.
        Enzymatic assay for gentamicin and related aminoglycoside antibiotics.
        J Infect Dis. 1974; 129: 519-527
        • Hull J.H.
        • Sarubbi F.A.
        Gentamicin serum concentrations: Pharmacokinetic predictions.
        Ann Intern Med. 1976; 85: 183-189
        • Jackson D.S.
        • Bertino Jr, J.S.
        Effects of heparin sodium on gentamicin assay measured by fluorescence polarization immunoassay.
        Ther Drug Monit. 1984; 6: 319-321
        • Jolley M.E.
        • Stroupe S.D.
        • Wang C.H.J.
        • et al.
        Fluorescence polarization immunoassay I. Monitoring aminoglycoside antibiotics in serum and plasma.
        Clin Chem. 1981; 27: 1190-1197
        • Kassai M.
        Measurement of serum gentamicin levels on open reagent analyzers using Du Pont Petenia reagents (abstract).
        Clin Chem. 1985; 31: 934
        • Kaye D.
        • Levison M.E.
        • Labovitz E.D.
        The unpredictability of serum concentrations of gentamicin: Pharmacokinetics of gentamicin in patients with normal and abnormal renal function.
        J Infect Dis. 1974; 130: 150-154
        • Krogstad D.J.
        • Granich G.G.
        • Murray P.R.
        • et al.
        Heparin interferes with the radioenzymatic and homogeneous enzyme immunoassay for aminoglycosides.
        Clin Chem. 1982; 28: 1517-1521
        • Lampasona V.
        • Crass R.E.
        Patient selection for serum gentamicin levels.
        Ther Drug Monit. 1983; 5: 255-262
        • Lando D.
        • Cousin M.A.
        • Privat de Garilhe M.
        Misreading, a fundamental aspect of the mechanisms of action of several aminoglycosides.
        Biochemistry. 1973; 12: 4528-4533
        • Lesar T.S.
        • Rotschafer J.C.
        • Strand L.M.
        • et al.
        Gentamicin dosing errors with four commonly used nomograms.
        JAMA. 1982; 248: 1190-1193
        • Ling G.V.
        • Conzelman G.M.
        • Franti C.E.
        • et al.
        Urine concentrations of gentamicin, tobramycin, amikacin and kanamycin after subcutaneous administration to healthy adult dogs.
        Am J Vet Res. 1981; 42: 1792-1794
        • Maddox R.R.
        • Lampasona V.
        Administrative aspects of clinical pharmacokinetic services.
        Top Hosp Pharm Management. 1982; 2: 61-73
        • Mahmod S.
        • Al-Hakiem M.H.H.
        • Landon J.
        • et al.
        Aminoglycoside antibiotics do not appear in saliva.
        Clin Chem. 1983; 29: 988-989
        • Maitra S.K.
        • Yoshikawa T.T.
        • Guze L.B.
        • et al.
        Determination of aminoglycoside antibiotics in biologic fluids: A review.
        Clin Chem. 1979; 25: 1361-1367
        • Mayhew J.W.
        • Gorbach S.L.
        Assay of gentamicin and tobramycin in sera of patients by gasliquid chromatography.
        Antimicrob Agents Chemother. 1978; 14: 851-855
        • Mayhew J.W.
        • Gorbach S.L.
        Gas-liquid chromatographic method for the assay of aminoglycoside antibiotics in serum.
        J Chromatogr. 1978; 151: 133-146
        • Mays D.L.
        • Van Apeldoorn R.J.
        • Lauback R.G.
        High performance liquid chromatographic determination of kanamycin.
        J Chromatogr. 1976; 120: 93-102
        • Meyer R.D.
        Amikacin.
        Ann Intern Med. 1981; 95: 328-332
        • Moore R.D.
        • Smith C.R.
        • Lietman P.S.
        The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.
        J Infect Dis. 1984; 149: 443-448
        • Moore R.D.
        • Smith C.R.
        • Lietman P.S.
        Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia.
        Am J Med. 1984; 77: 657-662
        • Morin J.P.
        • Fillastre J.P.
        Aminoglycoside-induced lysosomal dysfunctions in kidney.
        in: Whelton A. Neu H.C. The Aminoglycosides: Microbiology, Clinical Use and Toxicology. Marcel Dekker, New York1982: 303-324
      50. Mouton R.P. Aminoglycoside Assays: Methods and Clinical Relevance. Excerpta Medica, Amsterdam1979
        • Pechere J.C.
        • Dugal R.
        Clinical pharmacokinetics of aminoglycoside antibiotics.
        Clin Pharmacokinet. 1979; 4: 170-199
        • Plantier J.
        • Forrey A.W.
        • O’Neil M.A.
        • et al.
        Pharmacokinetics of amikacin in patients with normal and impaired renal function: Radioenzymatic acetylation assay.
        J Infect Dis. 1976; 134: 323-330
        • Rost W.J.
        Chemistry of the aminoglycosides: Strueture/function relationships.
        in: Barnes W.G. Hodges G.R. The Aminoglycoside Antibiotics: A Guide to Therapy. CRC Press, Boca Raton, Florida1984: 1-21
        • Rotschafer J.C.
        • Berg H.G.
        • Nelson R.B.
        • et al.
        Observed differences in gentamicin pharmacokinetic parameters and dosage recommendations determined by fluorescent polarization immunoassay and radioimmunoassay methods.
        Ther Drug Monit. 1983; 5: 443-447
        • Sabath L.D.
        • Casey J.I.
        • Ruch P.A.
        • et al.
        Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin and vancomycin in serum or plasma.
        J Lab Clin Med. 1971; 78: 457-463
        • Sarubbi F.A.
        • Hull J.H.
        Amikacin serum concentrations: Prediction of levels and dosage guidelines.
        Ann Intern Med. 1978; 89: 612-618
        • Sawchuk R.J.
        • Zaske D.E.
        • Cipolle R.J.
        • et al.
        Kinetic model for gentamicin dosing with the use of individual patient parameters.
        Clin Pharmacol Ther. 1976; 21: 362-369
        • Sawchuk R.J.
        • Zaske D.E.
        Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: Gentamicin in burn patients.
        J Pharmacokinet Biopharm. 1976; 4: 183-194
        • Schentag J.J.
        • Jusko W.J.
        Renal clearance and tissue accumulation of gentamicin.
        Clin Pharmacol Ther. 1977; 22: 364-370
        • Schwartz S.N.
        • Pasin G.J.
        • Lyon J.A.
        • et al.
        A controlled investigation of the pharmacokinetics of gentamicin and tobramycin in obese subjects.
        J Infect Dis. 1978; 138: 499-505
        • Sheiman M.
        • Srebro S.
        • Tokarski R.
        • et al.
        Radial partition immunoassay: Amikacin in serum (abstract).
        Clin Chem. 1985; 31: 933
        • Siber G.R.
        • Echevernia P.
        • Smith A.L.
        • et al.
        Pharmacokinetics of gentamicin in children and adults.
        J Infect Dis. 1975; 132: 637-651
        • Standefer J.C.
        • Saunders G.C.
        Enzyme immunoassay for gentamicin.
        Clin Chem. 1978; 24: 1903-1907
        • Tai P.C.
        • Wallace B.J.
        • Davis B.D.
        Streptomycin causes misreading of natural messenger by interacting with ribosomes after initiation.
        Proc Natl Acad Sci USA. 1978; 75: 275-279
        • Tsuji K.
        High pressure liquid chromatography of antibiotics.
        in: Hash J.H. Methods in Enzymology. Academic Press, New York1975 (Volume 43.)
        • Tsuji K.
        • Robertson J.H.
        • Baas R.
        • et al.
        Comparative study of responses of neomycins B and C by microbiological and gas-liquid chromatographic assay methods.
        Appl Microbiol. 1969; 18: 396-399
        • Weinstein A.J.
        • McHenry M.C.
        • Gavan T.L.
        Systemic absorption of neomycin irrigating solution.
        JAMA. 1977; 238: 152-153
        • Whiting P.H.
        • Barber H.E.
        • Petersen J.
        Effect of furosemide and piretanide on renal clearance of gentamicin in man.
        Br J Clin Pharmacol. 1981; 12: 795-799
        • Woo F.L.
        • Johnson A.P.
        • Insler M.S.
        • et al.
        Gentamicin, tobramycin, amikacin and netilmicin levels in tears following IV administration.
        Arch Ophthalmol. 1985; 103: 216-218
        • Yee G.C.
        • Evans W.E.
        Reappraisal of guidelines for pharmacokinetic monitoring of aminoglycosides.
        Pharmacotherapy. 1981; 1: 55-74
        • Zaske D.E.
        • Cipolle R.J.
        • Strate R.J.
        Gentamicin dosage requirements: Wide interpatient variations in 242 surgery patients with normal renal function.
        Surgery. 1980; 87: 164-169

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30727-3

      Copyright

      © 1987 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX